AD-054.9

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAD-054.9
Drug Alias NameAD-054.9 (Adamed Group)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTNF-related apoptosis-inducing ligand receptors agonistsPlatelet-derived growth factor receptor inhibitors
TargetsTNF-related apoptosis-inducing ligand receptorsPlatelet-derived growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdamed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdamed
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A